{
  "id": 20052705,
  "title": "Phio Pharmaceuticals director David Deming buys $10,066 in stock",
  "url": "https://urgent.news/2026/11/14/phio-pharmaceuticals-director-david-deming-buys-10-066-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-14T20:45:57.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/phio-pharmaceuticals-director-david-deming-buys-10066-in-stock-93CH-5027510"
  },
  "original_language": "en",
  "account": "Phio Pharmaceuticals Director David Deming boosted his stake in the company through two rounds of stock purchases totaling $10,066. These transactions transpired over the course of two days, with each share priced between $0.838 and $0.8395. The purchases were made in the wake of the stock trading near its lowest point in the past 52 weeks, which is currently $0.75 - a decrease of approximately 41% over the last year. On November 10, 2026, Deming bought 6,800 shares at an average price of $0.8395 per share, with the shares acquired in several transactions costing anywhere from $0.8079 to $0.8600. The following day, November 11, 2026, he bought an additional 5,200 shares at an average cost of $0.838 per share, with prices per share for these shares ranging from $0.8269 to $0.8600. Deming's total direct ownership in Phio Pharmaceuticals Corp. common stock is now 49,800 shares, which also includes shares tied to unvested restricted stock units. For those looking for more in-depth analysis, InvestingPro provides 13 ProTips for PHIO, including Fair Value assessments and financial health indicators to evaluate this $9.7 million market cap biotech firm.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}